Protective efficiency of DNA vaccination in Asian seabass (Lates calcarifer) against Vibrio anguillarum

Fish and Shellfish Immunology

Volumn 23, Issue 2, 2007, Pages 316-326

  Kumar, S Rajesh ^a   Parameswaran, V ^a   Ahmed, V P Ishaq ^a   Musthaq, S Syed ^a   Hameed, A S Sahul ^a  

^a C ABDUL HAKEEM COLLEGE   (India)

Author keywords

Outer membrane protein (OMP38); pVAOMP38; Seabass (Lates calcarifer); Seabass kidney cell line (SISK); Vibrio anguillarum

Indexed keywords

BACTERIA (MICROORGANISMS); EUKARYOTA; LATES CALCARIFER; LISTONELLA ANGUILLARUM; VIBRIO;

EID: 34248578736     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2006.11.005     Document Type: Article

References (53)

1. Rucker R.R., Earp B., and Ordal E. Infectious diseases of Pacific Salmon. Trans Am Fisheries Soc 83 (1953) 307-312
2. Austin B., and Austin D.A. Bacterial fish pathogens. Disease of farmed and wild fish (1999), Springer-praxis, Chichester
3. Wong S.Y., and Leong T.S. A comparative study of Vibrio infections in healthy and diseases marine finfishes cultured in floating cages near Penang, Malaysia. Asian Fish Sci 3 (1989) 353-359 [special issue]
4. Anderson I.G., and Norton J.H. Diseases of barramundi in aquaculture. Aust Aquacult 5 (1991) 21-24
5. Subhasinghe R.P., and Shariff M. Multiple bacteriosis, with special reference to spoilage bacterium Shewanell putrefaciens, in cage culture barramundi in Malaysia. J Aquat Anim Health 4 (1992) 309-311
6. Soltani M., Munday B.L., and Burke C.M. The relative susceptibility of fish to infections by Flexibacter columnaris maritimus. Aquaculture 140 (1996) 259-264
7. Azad I.S., Thirunavukkarasu A.R., Kailasam M., and Rajan J.J.S. Virulence and histopathology of Vibrio anguillarum like (VAL) bacterium isolated from hatchery produced juveniles of Lates calcarifer (Bloch). Asian Fish Sci 17 (2004) 101-110
8. Toranzo A.E., and Barja J.L. A review of the taxonomy and seroepizootiology of Vibrio anguillarum, with special reference to aquaculture in the Northwest of Spain. Dis Aquat Org 9 (1990) 73-82
9. Joosten P.H.M., Tiemersma E., Threels A., Caumartin-Dhieux C., and Rombout J.H.W.M. Oral vaccination of fish against Vibrio anguillarum using alginate microparticles. Fish Shellfish Immunol 7 (1997) 471-485
10. Coeurdacier J.L., Pepin J.F., Fauvel C., Legall P., Bourmaud A.F., and Romestand B. Alterations in total protein, IgM and specific antibody activity of male and female sea bass (Dicentrarchus labrax L., 1758) sera following injection with killed Vibrio anguillarum. Fish Shellfish Immunol 7 (1997) 151-160
11. Boesen H.T., Pedersen K., Koch C., and Larsen J.L. Immune response of Rainbow trout (Oncorhynchus mykiss) to antigenic preparations from Vibrio anguillarum serogroup O1. Fish Shellfish Immunol 7 (1997) 543-553
12. Heppell J., and Davis H.L. Application of DNA vaccine technology to aquaculture. Adv Drug Deliv Rev 43 (2000) 29-43
13. Kwang J. Fishing for vaccines. Nat Biotechnol 18 (2000) 1145-1146
14. Wang S.Y., Lauritz J., Jass J., and Milton D.L. Role for the major outer membrane protein from Vibrio anguillarum in bile resistance and biofilm formation. Microbiology 149 (2003) 1061-1071
15. Horne M.T., and Baxendale A. The adhesion of Vibrio anguillarum to host tissues and its role in pathogenesis. J Fish Dis 6 (1983) 461-471
16. Olsson J.C., Joborn A., Westerdahl A., Blomberg L., Kjelleberg S., and Conway P.L. Is turbot, Scophthalmus maximus (L.), intestine a portal of entry for the fish pathogen Vibrio anguillarum. J Fish Dis 19 (1996) 225-234
17. Olsson J.C., Joborn A., Westerdahl A., Blomberg L., Kjelleberg S., and Conway P.L. Survival, persistence, and proliferation of Vibrio anguillarum in juvenile turbot, Scophthalmus maximus (L.), intestine and faeces. J Fish Dis 21 (1998) 1-10
18. Costerton J.W., Cheng K.J., Geesy G.G., Ladd T.I., Nickel J.C., Dasgupta M., et al. Bacterial biofilms in nature and Diseases. Annu Rev Microbiol 41 (1987) 435-464
19. Costerton J.W., Lewandowski Z., Caldwell D.E., Korber D.R., and Lappin-scott H. Microbial biofilms. Annu Rev Microbiol 49 (1995) 711-745
20. Simón M., Mathes A., Blanch A., and Engelhardt H. Characterization of a porin from the outer membrane of Vibrio anguillarum. J Bacteriol 178 14 (1996) 4182-4188
21. Evaluation of the immunospecificity of the porin om1 of Vibrio anguillarum serotype 01. J Appl Microbiol 84 5 (1998) 709-714
22. Lorenzen N., Lorenzen E., Einer-Jensen K., Heppell J., Wu T., and Davis H. Protective immunity of VHS in rainbow trout (Oncorhynchus mykiss, Walbaum) following DNA vaccination. Fish Shellfish Immunol 8 (1998) 261-270
23. Corbeil S., LaPatra S.E., Anderson E.D., Jones J., Vincent B., Hsu Y.L., et al. Evaluation of the protective immunogenicity of the N, P, M, NV and G proteins of infectious hematopoietic necrosis virus in rainbow trout Oncorhynchus mykiss using DNA vaccines. Dis Aquat Org 39 (1999) 29-36
24. Vazquez-Juarez R.C., Gomez-Chiarri M., Barrera-Saldana H., Hernandez-Saavedra N., Dumas S., and Ascencio E. Evaluation of DNA vaccination of spotted sand bass (Paralabrax maculatofasciatus) with two major outer-membrane protein-encoding genes from Aeromonas veronii. Fish Shellfish Immunol 19 (2005) 153-163
25. Amend D.F. Potency testing of fish vaccines. In: Anderson D.P., and Hennessen H. (Eds). Fish biologics: serodiagnostics and vaccines. Developments in biological standardisation (1981), Karger, Basel 447-454
26. Jung C.R., Park M.I., and Hoe M.S. Immunization with major outer membrane protein of Vibrio vulnificus elicits protective antibodies in a murine model. J Microbiol 43 (2005) 437-442
27. Andre S., Seed B., Eberle J., Schraut W., Bultmann A., and Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol 72 (1998) 1497-1503
28. Uchijima M., Yoshida A., Nagata T., and Koide Y. Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J Immunol 161 (1998) 5594-5599
29. Nagata T., Uchijima M., Yoshida A., Kawashima M., and Koide Y. Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms. Biochem Biophys Res Commun 261 (1999) 445-451
30. Zur Megede J., Chen M.C., Doe B., Schaefer M., Greer C.E., Selby M., et al. Increased expression and immunogenicity of sequence-modified human immuno deficiency virus type 1 gag gene. J Virol 74 (2000) 2628-2635
31. Stratford R., Douce G., Zhang-Barber L., Fairweather N., Eskola J., and Dougan G. Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus. Vaccine 19 (2000) 810-815
32. Narum D.L., Kumar S., Rogers W.O., Fuhrmann S.R., Liang H., Oakley M., et al. Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. Infect Immun 69 (2001) 7250-7253
33. Cid-Arregui A., Juarez V., and Zur Hausen H. A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J Virol 77 (2003) 4928-4937
34. Penttila T., Vuola J.M., Puurula V., Anttila M., Sarvas M., Rautonen N., et al. Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2). Vaccine 19 (2001) 1256-1265
35. Zhang D.J., Yang X., Shen C., and Brunham R.C. Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain. Immunology 96 (1999) 314-321
36. Smooker P.M., Steeper K.R., Drew D.R., Strugnell R.A., and Spithill T.W. Humoral responses in mice following vaccination with DNA encoding glutathione S-transferase of Fasciola hepatica: effects of mode of vaccination and the cellular compartment of antigen expression. Parasite Immunol 21 (1999) 357-364
37. Svanholm C., Bandholtz L., Lobell A., and Wigzell H. Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion. J Immunol Methods 228 (1999) 121-130
38. Price B.M., Galloway D.R., Baker N.R., Gilleland L.B., Staczek J., and Gilleland Jr. H.E. Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa. Infect Immun 69 (2001) 3510-3515
39. Donnelly J.J., Liu M.A., and Ulmer J.B. Antigen presentation and DNA vaccines. American J Respir Crit Care Med 162 (2000) S190-S213
40. Deliyannis G., Boyle J.S., Brady J.L., Brown L.E., and Lew A.M. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc Natl Acad Sci USA 97 (2000) 6676-6680
41. Fredriksen A.B., Sabdkue I., and Bogen B. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells. Mol Ther 13 (2006) 776-785 [Epub 2006 Jan 18]
42. Meng Z., Shao J., and Xiang L. CpG oligodeoxynucleotides activate grass carp (Ctenopharyngodon idellus) macrophages. Dev Comp Immunol 27 (2003) 313-321
43. Ioannou X.P., Gomis S.M., Karvonen B., Hecker R., Babiuk L.A., and Van Drunen Littel-van den Hurk S. CpG containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpes virus glycoprotein. Vaccine 21 (2002) 127-137
44. Ioannou X.P., Griebel P., Hecker R., Babiuk L.A., and VanDrunen Littel-van den Hurk S. The immunogenicity and protective efficacy of bovine herpes virus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligo-deoxynucleotides. J Virol 76 (2002) 9002-9010
45. Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M., et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol 160 (1998) 870-876
46. Klinman D.M., Barnhart K.M., and Conover J. CpG motifs as immune adjuvants. Vaccine 17 (1999) 19-25
47. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., and Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186 (1997) 1623-1631
48. Zhang D., Yang X., Berry J., Shen C., McClarty G., and Brunham R.C. DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis 176 (1997) 1035-1040
49. Lutwyche P., Exner M.M., Hancock R.E., and Trust T.J. A conserved Aeromonas salmonicida porin provides protective immunity to rainbow trout. Infect Immun 63 (1995) 3137-3142
50. Yin Z., Lam T.J., and Sin Y.M. The role of specific antiserum of catfish, Clarias gariepinus, as a defence against Aeromonas hydrophila. Fish Shellfish Immunol 6 (1996) 57-69
51. Chandran M.R., Aruna B.V., Logambal S.M., and Michael R.D. Immunisation of Indian major carps against Aeromonas hydrophila by intraperitoneal injection. Fish Shellfish Immunol 13 (2002) 1-9
52. Bricknell I.R., King J.A., Bowden T.J., and Ellis A.E. Duration of protective antibodies, and the correlation with protection in Atlantic salmon (Salmo salar L.) following vaccination with an Aeromonas salmonicida vaccine containing iron-regulated outer membrane proteins and secretory polysaccharide. Fish Shellfish Immunol 9 (1999) 139-151
53. Boesen H.T., Larsen J.L., and Ellis A.E. Bactericidal activity by sub-agglutinating levels of rainbow trout (Oncorhynchus mykiss) antiserum to Vibrio anguillarum serogroup O1. Fish Shellfish Immunol 9 (1999) 633-636